Improving T2DM outcomes by revising current clinical approaches – Expert review of ADA/EASD Guidelines
This review of T2DM management by well-known endocrinologist, Prof Julio Rosenstock, describes his clinical approach using simultaneous therapy in early and later therapeutic regimens
Learning objectives
You will learn:
- To prioritise a clinical emphasis on using combination therapy with oral agents as well as the fixed-ratio combination of injectables (basal insulin plus GLP-1RA) to achieve sustained glycaemic control in type 2 diabetes mellitus (T2DM)
- To interpret, from expert guidance, the value and evidence for simultaneous therapeutic interventions rather than a step-wise approach as currently outlined in international guidelines, such as the ADA/EASD Guidelines for Type 2 Diabetes.
To access this module, please register or login: